LAS VEGAS, NV / ACCESSWIRE / April 26, 2016 / As Neutra Corp. (OTCQB: NTRR) works to increase its footprint in the North American cannabis industry, the marketplace's historic rise is forecast to hit a new peak this year. The size of the market for regulated cannabis in the United States is projected to reach $7.1 billion in 2016, according to a report by New Frontier and ArcView Market Research.
The astounding figure, reported by Forbes, represents growth of 26 percent over last year's total. The incredible expansion of the market is being driven by adult-use legalization, with seven more states now poised to consider adult-use legislation: Arizona, California, Massachusetts, Maine, Nevada, Rhode Island and Vermont.
Such rapid growth has led to significant challenges for the industry, including supplying a huge amount of cannabis crops without the use of potentially hazardous pesticides and making cannabis treatments safer, more discrete and more reliable for patients.
With help from joint venture partner Surface to Air Solutions, Inc. (S2O2), NTRR is hard at work marketing and promoting antimicrobial alternatives to harsh chemicals used in cannabis farms. In 2016, NTRR plans to continue to source out solutions for cannabis producers and consumers alike as the regulated cannabis industry continues to swell in the United States, Canada and beyond. For more information on the company's mission, please visit http://neutrainc.com/investors.
About Neutra Corp.
As the global cannabis market grows exponentially, it is constantly in need of better technologies and products to be more efficient in how they grow, what they grow, and how they consume cannabis and its related products. From lighting to dosage devices, from pesticide replacements to plant enhancers, NTRR is constantly combing the industry for the latest and greatest to test, prove and bring to market.
By providing a variety of new technologies designed to ensure safer, more reliable access to cannabis in approved markets, Neutra Corp. plans to compete alongside GW Pharmaceuticals (GWPH), Cara Therapeutics Inc. (CARA) and 22nd Century Group, Inc. (XXII). For investing information and performance data, please visit www.neutrainc.com.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.
Contact:
Neutra Corp.
Chris Brown, 813-367-2041
President and CEO
[email protected]
SOURCE: Neutra Corp.